This interview on Gentle Monster with Darragh Matthews, Investment Manager of IPR.VC, is part of The Market Insider, an industry-focused podcast conducted in collaboration with FRED Film Radio during the 79th Cannes Film Festival.
The Importance of IPR.VC
IPR.VC is the London and Helsinki based investment fund, active for more than 10 years in the film and audiovisual business, contributing to the making of many successful films.
One of these is Gentle Monster by Marie Kreutzer, in the Official Competition of the 79° Cannes Film Festival.
Uncovering the Artistic and Commercial Appeal of Gentle Monster
Gentle Monster is a provocative film that explores societal taboos through the story of a woman facing an unexpected crisis in her family life. Marie Kreutzer, the director, has crafted an emotionally intense narrative that challenges audiences to confront uncomfortable truths. Its strong cast, including Lea Seydoux and Catherine Deneuve, and the compelling script are key elements that contributed to its appeal. Moreover, the film’s relevance to current societal issues, and the commercial success of Marie Kreutzer’s previous film Corsage, also sold by MK2.
The Production and Market Strategy Behind Gentle Monster
With Darragh Matthews, we explore this European co-production sold by MK2, whose journey from development to festival recognition showcases the importance of strategic collaborations and funding in bringing daring projects to life.
The film is a European co-production involving Austria, France, and Germany, supported by regional funds and private investment. Its financing structure highlights the value of integrating soft money and international collaboration in today’s film industry.
Its successful participation in the Cannes Investors Circle, where it won the Artekino International Prize, underscores its recognition among private investors and its promising commercial prospects. The mix of private funding with European soft money exemplifies modern funding models that support bold, artistic cinema like Gentle Monster, which seeks both critical acclaim and market success.